Clinical Trial Update: Nicotinamide Versus Sevelamer Hydrochloride on Phosphatemia Control on Chronic Hemodialysed Patients [Phase 3]

View source ↗

Summary

Phase 3 trial comparing nicotinamide with sevelamer hydrochloride for phosphatemia control in chronic kidney disease patients on hemodialysis was terminated. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• Nicotinamide (nicotinamide)
• Sevelamer hydrochloride (sevelamer hydrochloride)

Snippet

Sponsor: Centre Hospitalier Universitaire, Amiens | Conditions: Chronic Renal Failure, Hemodialysis | Phase 3 | Status: TERMINATED